A longitudinally measured disease progression-marker data analysis of HIV/TB co-infected   patients taking HAART drugs in a public Hospital, Ethiopia

Author:

Gebreyes Delelegn Eshete1

Affiliation:

1. Ethiopian Environment and Forest Research Institute

Abstract

Abstract Background The applications of HAART drugs play a great role in decreasing the incidence of TB and TB related death in persons living with HIV/AIDS. However, after HAART initiation, a considerable number of the TB infection and TB-HIV damages are still at a shocking level especially we could understand that the addition of TB to this damage made things “Mumps on the Goiter”. Methods A 407 co-infection patients data under HAART follow up and diagnosed for TB were analyzed using linear mixed model to explain the effects of HAART treatment for the improvement of patient’s CD4 count. The appropriate fixed and random effect model was selected using AIC, BIC, and log-likelihood values. Results Out of a total of 407 HIV/TB co-infected patients, 196 (48.16%) were females. When we look at the baseline functional status of patients, 24.57% were able to do their day to day activities like farming, harvesting, office work and others, 62.16% were ambulatory and 13.27% were bedridden for all visit times. Based on linear mixed model, the study results reveal that, duration of treatment, age, marital status, functional status, ART_Regimen, education and base line CD4 + count were among the significant predictors of linear mixed effect model at 5% significance level for the change of CD4 + counts over time. Conclusions Linear mixed effect model with random intercept and random slope model, and an autoregressive of order 1 (AR (1)) covariance structure have been used to model this correlated data type and a random variables effect. Age, marital status, functional status, ART_Regimen, education and base line CD4 + count were identified as a potential risk factor for the progression of CD4 + count of the patients. Patients who have a good baseline CD4 count had a positive significant effect for the improvement of CD4 counts of the patients over time.

Publisher

Research Square Platform LLC

Reference32 articles.

1. A survival analysis of prognostic determinant factors of time-to-death of HIV / TB co-infected patients under HAART followed-up in a public hospital in Ethiopia;Gebreyes DE;Int J Hiv-related Probl HIV-AIDS Rev,2023

2. WHO. WHO publishes new clinical and service delivery recommendations for HIV prevention, treatment and care. Published online 2021. https://www.who.int/news/item/17-03-2021-who-publishes-new-clinical-recommendations-on-hiv-prevention-infant-diagnosis-antiretroviral-therapy-initiation-and-monitoring.

3. WHO. HIV and Tuberculosis, Published. online 2021. https://www.who.int/westernpacific/health-topics/hiv-aids/hiv-and-tuberculosis.

4. Fact Sheet - World Tuberculosis Day;UNAIDS;Unaids Published online,2022

5. WHO, Tuberculosis. 2022. Published online 2022. https://www.who.int/news-room/fact-sheets/detail/tuberculosis#:~:text=A total of 1.6 million,(above HIV%2FAIDS).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3